Mayne Pharma Group Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mayne Pharma Group Limited with three other
pharmaceutical manufacturers in Australasia:
AFT Pharmaceuticals Ltd
of New Zealand
sales of 64.01 million New Zealand Dollars [US$45.11 million]
of which 100%
(65.61 million Australian Dollars [US$49.22 million]
Vita Life Sciences Limited.
(37.86 million Australian Dollars [US$28.40 million]
During the year ended June of 2016, sales at
Mayne Pharma Group Limited were A$267.28 million (US$200.51 million).
increase of 89.0%
versus 2015, when the company's sales were A$141.42 million.
Sales of Metrics Contract Services (Mcs) saw an increase
44.7% in 2016, from
A$33.79 million to A$48.89 million.
Not all segments of Mayne Pharma Group Limited experienced an increase in sales in 2016:
sales of Mayne Pharma International (Mpi) fell 44.4% to A$33.74 million.